Genus Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 3/6

Genus 1.53% cari getiri oranına sahip temettü ödeyen bir şirkettir.

Anahtar bilgiler

1.5%

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	1.7%
Temettü Büyümesi	5.7%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	-526%

Son temettü ve geri alım güncellemeleri

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Oct 23

Recent updates

Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry

May 10

An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued

Apr 18

Regulatory Approvals And Sustainability Initiatives Will Strengthen Future Market Position

Feb 11 Expansion in the porcine business and PRRS resistant pig commercialization boosts revenue stability and growth through innovation and market penetration.

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Feb 01

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Nov 17

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Oct 25

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Oct 11

Genus' (LON:GNS) Dividend Will Be £0.217

Sep 11

A Look At The Fair Value Of Genus plc (LON:GNS)

Sep 09

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

May 31

Is Genus (LON:GNS) A Risky Investment?

Mar 29

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Feb 27

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 22

With EPS Growth And More, Genus (LON:GNS) Is Interesting

Oct 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: GNS şirketinin hisse başına düşen temettüsü son 10 yıldır istikrarlıydı.

Büyüyen Temettü: GNS şirketinin temettü ödemeleri son 10 yıldır artış göstermektedir.

Piyasaya Karşı Temettü Getirisi

Genus Piyasaya Karşı Temettü Getirisi

GNS temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (GNS)	1.5%
Pazarın Alt %25'i (GB)	2.2%
Pazarın En İyi %25'i (GB)	5.7%
Sektör Ortalaması (Biotechs)	2.1%
Analist tahmini (GNS) (3 yıla kadar)	1.7%

Önemli Temettü: GNS şirketinin temettüsü ( 1.53% ), UK pazarındaki temettü ödeyenlerin en alttaki %25'ine ( 2.19% ) kıyasla dikkate değer değil.

Yüksek Temettü: GNS 'in temettüsü ( 1.53% ), UK piyasasındaki temettü ödeyenlerin en üst %25'ine ( 5.66% ) kıyasla düşüktür.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: GNS temettü ödüyor ancak şirket kâr etmiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Makul nakit ödeme oranı ( 67.2% ) ile GNS 'un temettü ödemeleri nakit akışları ile karşılanmaktadır.

Güçlü temettü ödeyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/05/20 20:16
Gün Sonu Hisse Fiyatı	2025/05/20 00:00
Kazançlar	2024/12/31
Yıllık Kazançlar	2024/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Genus plc 20 Bu analistlerden 9, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Robert Chantry	Berenberg
Alexander Jones	BofA Global Research
Matthew John Yates	BofA Global Research

Genus Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 3/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

First half dividend of UK£0.10 announced

Genus plc Declares A Final Dividend

Upcoming dividend of UK£0.22 per share

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Final dividend of UK£0.22 announced

Genus plc Proposes Final Dividend for the Year Ended June 30, 2024, Payable on 6 December 2024

Recent updates

Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry

Genus plc Announces the Update in Relation to Its Innovative Prrs 1 Resistant Pig Programme

An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued

Now 21% undervalued after recent price drop

Now 20% undervalued

Genus plc Appoints Andy Russell as Chief Financial Officer, Effective August 1, 2025

Chief Executive Officer & Director exercised options and sold UK£346k worth of stock

First half dividend of UK£0.10 announced

Genus plc Announces Retirement of Jason Chin as Non-Executive Director from the Board, Effective from the End of May 2025

Regulatory Approvals And Sustainability Initiatives Will Strengthen Future Market Position

Now 21% undervalued after recent price drop

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Consensus EPS estimates increase by 18%

New minor risk - Share price stability

Price target decreased by 8.0% to UK£24.23

Genus plc to Report Fiscal Year 2025 Results on Sep 04, 2025

Genus plc Declares A Final Dividend

Lacklustre Performance Is Driving Genus plc's (LON:GNS) Low P/S

Genus plc to Report First Half, 2025 Results on Feb 27, 2025

Now 21% undervalued

Upcoming dividend of UK£0.22 per share

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Genus plc Announces Retirement of Alison Henriksen as Chief Financial Officer, Until 31 July 2025

There May Be Some Bright Spots In Genus' (LON:GNS) Earnings

Full year 2024 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 19%

Consensus EPS estimates fall by 29%

Genus plc Just Missed EPS By 72%: Here's What Analysts Think Will Happen Next

Final dividend of UK£0.22 announced

Full year 2024 earnings: EPS misses analyst expectations

Genus plc Proposes Final Dividend for the Year Ended June 30, 2024, Payable on 6 December 2024

The Price Is Right For Genus plc (LON:GNS)

Price target decreased by 7.9% to UK£28.74

Estimating The Fair Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) Using Too Much Debt?

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 10% to UK£29.62

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

First half dividend of UK£0.10 announced

First half 2024 earnings released: EPS: UK£0.21 (vs UK£0.20 in 1H 2023)

Consensus EPS estimates fall by 23%

Investor sentiment deteriorates as stock falls 19%

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Genus Appoints Ralph Heuser as Non-Executive Director, with effect from 1 January 2024

Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

Genus plc to Report Fiscal Year 2024 Results on Sep 05, 2024

Genus plc Approves to Declare Final Dividend

We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Upcoming dividend of UK£0.22 per share at 1.4% yield

Full year 2023 earnings: EPS exceeds analyst expectations

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Executive Director exercised options and sold UK£194k worth of stock

Consensus EPS estimates fall by 19%

Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Full year 2023 earnings: EPS exceeds analyst expectations

Genus plc Announces Lykele Van Der Broek to Step Down from the Genus Board

AB Agri Ltd. completed the acquisition of National Milk Records plc (OFEX:NMRP) from Livestock Improvement Corporation Limited (NZSE:LIC), ICM Investment Management Limited, Genus plc (LSE:GNS), Custodial Capital Management Limited, High Street Partners, Ltd, and Working Capital Partners Ltd.

Price target decreased by 8.4% to UK£38.82

Now 20% undervalued after recent price drop

Price target decreased by 8.0% to UK£40.28

Is Genus (LON:GNS) A Risky Investment?

First half 2023 earnings released: EPS: UK£0.20 (vs UK£0.30 in 1H 2022)

Is Genus (LON:GNS) Using Too Much Debt?

Price target decreased to UK£40.14

Genus plc to Report Fiscal Year 2023 Results on Sep 07, 2023

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Investor sentiment improved over the past week